Harbor MedTech, Inc. is a diversified and fully integrated biologics tissue regeneration company founded in 2010 and based in Irvine, California.  Harbor’s proprietary technology, BriDGE® enables the development of a broad range of biologic products for tissue regeneration.  Harbor’s first product, Architect®, is a collagen matrix used as a skin substitute for treating diabetic foot ulcers, venous leg ulcers, serious burns, and many other chronic skin wounds. Architect® is already FDA approved and approved in Europe for helping heal chronic skin wounds. Harbor’s future products include EPMatrix™ for reinforcing the repair of soft tissue injuries such as hernias and torn ligaments and tendons.   

Harbor MedTech is headquartered in Irvine, CA.